Astrana Health, Inc.
ASTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 46.7% | 21.2% | 47.8% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 13.3% | 15.5% | 17.4% | 23% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 4.4% | 6.1% | 9.1% | 12.7% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 2.1% | 4.4% | 3.9% | 8.9% |
| EPS | 0.91 | 1.3 | 1 | 1.57 |
| % Growth | -30% | 30% | -36.3% | – |
| EPS Diluted | 0.9 | 1.29 | 0.99 | 1.52 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7% | 8.9% | 9.8% | 13% |